Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: POBA
Total 0 results
Nothing found
Sponsors and Collaborators
Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal
Minnesota Medical Development, Inc.
Ministry of Science and Technology of the People´s Republic of China
Etwal Ltd.
Klinik Bad Oexen, Germany
Ataturk University SCIENTIFIC RESEARCH PROJECTS COORDINATION UNIT
Olynka Vega Vega
Eva Klappe
Huan Wang, MD
Alaska Department of Health and Social Services
Enrique Ordiñaga-Monreal, OD, MSc
AdhereTech
University Grants Committee, Hong Kong
The Danish Midwifery Organization
WuHui
NYC RING, Director
Maryland Treatment Centers @ ARTC
Academia Sinica, Taiwan
The Third People's Hospital of Hubei Province
William Xu, MD
View Full List
Medical Conditions
Optim Lead Insulation Related Adverse Events
Recurrent Pleural Effusions
Piperacillin, Tazobactam Drug Combination
Gastric Submucosal Tumors
Venetoclax Combined With Azacitidine
Advanced Intestinal Cancer
Human Mammary Carcinoma
Post-nasal Drip
Cervical Spine Sprain
Infertilities
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Aneurysmal Subarachnoid Hemorrhage, Familial
Primary Hypomagnesemia (Disorder)
Urinary Incontinence in Geriatric Population
Food IgE-mediated Allergy
Musculoskeletal Injury
Orthodontics, Corrective, Palatal Expansion Technique
Accidental Injuries
Chronic Hepatitis C Genotype 1B
Primary Intestinal Lymphangiectasia
View Full List
Drug Interventions
Cyclosporine 0.010%
Ivermectin
Viread 300Mg Tablet
Extremecare
Urokinase
SD-101
Peginterferon alfa-2a
PHA-022121 selected dose
2B3-101 50 mg/m2 every 3 weeks
YYC301-1 & YYC301-2 & YYC301-3
Experimental drug: ESK-001
Bempedoic Acid 180 MG Oral Tablet
DP001
Neem plus propylene glycol plus salicylic acid
SOF/VEL
Peg-Interferon alpha-2b
Docetaxel Injection
Vitamin D
Niacin
ASP8825
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Azerbaijan
Contract Research Organizations in India
Contract Research Organizations in Iran
Contract Research Organizations in Malaysia
Contract Research Organizations in New Zealand
Contract Research Organizations in Nigeria
Contract Research Organizations in Norway
Contract Research Organizations in Peru
Contract Research Organizations in Rwanda
Contract Research Organizations in Senegal
Contract Research Organizations in Spain
Contract Research Organizations in Vietnam
CRO list by country
CROs in Zimbabwe
SGS
All CROs in Zimbabwe
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe